Evaluation of long-term efficacy of supplementary Lei's Danshen Tablet therapy in ischemic cardiomyopathy patients with heart failure
- VernacularTitle:雷氏丹参片佐治缺血性心肌病伴心功能不全的长期疗效评价
- Author:
Xiaoying LUO
;
Fengru ZHANG
;
Wenhang QI
- Publication Type:Journal Article
- Keywords:
Danshen Tablet;
ischemic cardiomyopathy;
heart failure
- From:
Chinese Traditional Patent Medicine
1992;0(11):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To evaluate the long-term clinical efficacy of supplementary Danshen Tablet therapy in ischemic cardiomyopathy patients with heart failure. METHODS: 100 ischemic cardiomyopathy patients with heart fai-lure were randomly assigned into two groups,Danshen group(50 patients) and conventional therapy group(50 patients).The patients in Danshen group were administrated Danshen Tablet(three tablets a time,three times a day) plus conventional therapy for one year.NYHA functional class,6 min walking-distance,echocardiographic indices,major-adverse-cardiovascular-events(MACE) and mortality were evaluated before and after 1 year therapy.(RESULTS):(After) 1 year therapy,the improvements of NYHA functional class and 6 min walking-distance were more significantly effective in Danshen group than those in conventional group(P
